EUVIMEDEUVIMED entdecken
Crossref

Eribulin mesylate: A new therapeutic option for metastatic breast cancer

Suruchi Aditya

Journal of Basic and Clinical Reproductive Sciences · 2013

DOI: 10.4103/2278-960x.112571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Basic and Clinical Reproductive Sciences, 2013. Verfasst von Suruchi Aditya. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Aditya, S. (2013). Eribulin mesylate: A new therapeutic option for metastatic breast cancer. Journal of Basic and Clinical Reproductive Sciences. https://doi.org/10.4103/2278-960x.112571

Vancouver

Aditya S. Eribulin mesylate: A new therapeutic option for metastatic breast cancer. Journal of Basic and Clinical Reproductive Sciences. 2013. doi:10.4103/2278-960x.112571

BibTeX
@article{Aditya2013,
  author = {Aditya, Suruchi},
  title = {Eribulin mesylate: A new therapeutic option for metastatic breast cancer},
  journal = {Journal of Basic and Clinical Reproductive Sciences},
  year = {2013},
  doi = {10.4103/2278-960x.112571}
}
Kostenlos starten →